Neutrophil profile in multiple sclerosis and neuromyelitis optica
Laura Hertwig(Karolinska University Hospital), Friedemann Paul(Max Delbrück Center), Nadja Borisow(Max Delbrück Center), Florence Pache(Heidelberg University), Klemens Ruprecht(Charité - Universitätsmedizin Berlin), Carmen Infante‐Duarte(Charité - Universitätsmedizin Berlin), Janina Behrens(Charité - Universitätsmedizin Berlin), Klarissa Hanja Stürner(Universität Hamburg), Jason M. Millward(Charité - Universitätsmedizin Berlin), Silvina Romero(Charité - Universitätsmedizin Berlin)
Cited by 0
Related Papers
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome
|Journal of Neuroinflammation|2016|896
MOG encephalomyelitis: international recommendations on diagnosis and antibody testing
|Journal of Neuroinflammation|2018|740
Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial
|The Lancet|2019|722
Update on the diagnosis and treatment of neuromyelitis optica: Recommendations of the Neuromyelitis Optica Study Group (NEMOS)
|Journal of Neurology|2013|604
Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis
|The Lancet Neurology|2017|572